Immune globulin intravenous and subcutaneous Interactions
There are 106 drugs known to interact with immune globulin intravenous and subcutaneous, along with 2 disease interactions. Of the total drug interactions, 85 are major, and 21 are moderate.
- View all 106 medications that may interact with immune globulin intravenous and subcutaneous
- View immune globulin intravenous and subcutaneous disease interactions (2)
Most frequently checked interactions
View interaction reports for immune globulin intravenous and subcutaneous and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Ativan (lorazepam)
- B 100 Complex (multivitamin)
- Benadryl (diphenhydramine)
- Bentyl (dicyclomine)
- Bumex (bumetanide)
- Calcionate (calcium glubionate)
- Caltrate 600+D (calcium / vitamin d)
- Carafate (sucralfate)
- Cardizem (diltiazem)
- Cardura (doxazosin)
- Celebrex (celecoxib)
- CellCept (mycophenolate mofetil)
- Cequa (cyclosporine ophthalmic)
- Cipro (ciprofloxacin)
- Creon (pancrelipase)
- Crestor (rosuvastatin)
- D3 (cholecalciferol)
- Dexilant (dexlansoprazole)
- Dried Factor VIII Fraction Type 8Y (antihemophilic factor/von willebrand factor)
- Dulera (formoterol / mometasone)
- Ecotrin Maximum Strength (aspirin)
- Estro-Span 40 (estradiol)
- Fioricet (acetaminophen / butalbital / caffeine)
- Flebogamma (immune globulin intravenous)
- Lyrica (pregabalin)
- Plaquenil (hydroxychloroquine)
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
Immune globulin intravenous and subcutaneous disease interactions
There are 2 disease interactions with immune globulin intravenous and subcutaneous which include:
Report options
More about immune globulin intravenous and subcutaneous
- immune globulin intravenous and subcutaneous consumer information
- Compare alternatives
- Reviews (25)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: immune globulins
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Hizentra
Hizentra (immune globulin) is used as a replacement therapy in patients with primary humoral ...
Nplate
Nplate is used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura ...
Privigen
Privigen is used to treat primary immune deficiency conditions and idiopathic thrombocytopenic ...
Gammagard Liquid
Gammagard (immune globulin) is used to treat primary immune deficiency and multifocal motor ...
Octagam
Octagam (immune globulin intravenous) is used to treat primary immunodeficiency diseases, immune ...
Vyvgart Hytrulo
Vyvgart Hytrulo is used to treat generalized myasthenia gravis (gMG) or chronic inflammatory ...
Panzyga
Panzyga is used to treat primary humoral immunodeficiency (PI), chronic immune thrombocytopenia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.